Lab Notes — Fall 2019

The Key to Allergies

An unexpected source drives severe allergies, researchers from UConn Health, The Jackson Laboratory for Genomic Medicine, and Yale University report in Science. An antibody known as high-affinity IgE is often behind the most severe food allergies, triggering anaphylactic shock. The researchers looked at mice with a genetic immune problem that causes severe food allergies including anaphylaxis. They found a subtype of immune cells called Tfh13 signal to B cells, another category of immune cell, telling them to make high-affinity IgE. When the researchers deleted Tfh13 cells in mice, the allergies disappeared. People with severe allergies tend to have elevated Tfh13 levels compared with nonallergic peers. The findings could point the way to better allergy testing and perhaps new approaches for treating allergies.


Just Breathe

Yoga practice that emphasizes mental relaxation and breathing techniques can have as much of a beneficial impact on high blood pressure as aerobic exercise, according to research by Yin Wu, Ph.D., a postdoctoral fellow in UConn’s Department of Kinesiology. The study, published in Mayo Clinic Proceedings, highlights the potential for yoga as an alternative antihypertensive therapy, particularly for those unable or unwilling to perform aerobic exercise. “We are not telling people to use yoga to substitute for aerobic exercise,” says Wu. “Aerobic exercise is the gold standard for antihypertensive lifestyle therapy. But yoga provides an additional option that can be just as effective.”


Caution: Falls Ahead

Antidepressant drugs known as selective norepinephrine reuptake inhibitors, or SNRIs, can lead to adverse events in adults over 65, according to a team of researchers from UConn School of Pharmacy, UConn Health, and Yale University. Among this drug class, duloxetine, which is commonly known as Cymbalta, was shown to most likely increase the risk of falls over time, according to the study published in the Journal of the American Geriatric Society. SNRIs, particularly duloxetine, should be avoided or used with caution in older adults, the researchers say.


Halting Hypertension’s Effects

Elderly people with hypertension who took a high dosage of medicine to manage their high blood pressure showed significantly less accumulation of harmful brain lesions compared to those taking a lower dose of the same medicine, UConn Health researchers reported at the American College of Cardiology’s 68th Annual Scientific Session. However, the reduction in brain lesions did not translate to a significant improvement in mobility and cognitive function. The INFINITY study is the first to demonstrate an effective way to slow the progression of cerebrovascular disease, a condition common in older adults that restricts the flow of blood to the brain. In addition to seeing beneficial effects in the brain, those who kept their blood pressure lower also were less likely to suffer major cardiovascular events, such as a heart attack or stroke.


Related Articles

  • UConn Hosts Prader-Willi Stem Cell Biobank

    The stem cells will allow researchers around the world to better understand Prader-Willi syndrome and look for potential therapies for the rare genetic disease.

  • ConnectiCare Passage Plan Patients Now Accepted at UConn Health

    Members of passage plans are required to get primary care provider (PCP) referrals to see any specialist in the ConnectiCare network.

  • New Vascular Surgery Chief Stays a Step Ahead

    Dr. Kwame Amankwah may be new to UConn Health, but he has already made a big impact on the Department of Vascular and Endovascular Surgery. In his first few months, he performed an aortic dissection repair with a newly approved device that not only covers the tear that caused the dissection but also helps to […]

  • UConn Health Leads Search for Syphilis Vaccine

    UConn will receive up to $11 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a vaccine for this centuries-old disease.